Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | AHR | P35869 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4450644 | 0.82 | AHR (0.68) | TSHRHSD17B10ALDH1A1CYP3A4TDP1 | |
| SCHEMBL4459046 | 0.79 | TP53 (0.48) | TSHRHSD17B10ALDH1A1CYP3A4TDP1 | |
| SCHEMBL2280325 | 0.78 | HSD17B10 (0.48) | TSHRHSD17B10ALDH1A1CYP3A4TDP1 | |
| SCHEMBL4445026 | 0.77 | AHR (0.67) | TSHRHSD17B10ALDH1A1CYP3A4TDP1 | |
| SCHEMBL28330002 | 0.77 | HSD17B10 (0.46) | TSHRHSD17B10ALDH1A1CYP3A4TDP1 | |
| SCHEMBL2473835 | 0.77 | AHR (0.54) | TSHRHSD17B10ALDH1A1CYP3A4TDP1 | |
| SCHEMBL440944 | 0.75 | TP53 (0.61) | TSHRHSD17B10ALDH1A1CYP3A4TDP1 | |
| SCHEMBL29364307 | 0.75 | TP53 (0.61) | TSHRHSD17B10ALDH1A1CYP3A4TDP1 | |
| SCHEMBL3566720 | 0.75 | TTR (0.70) | TTRTSHRHSD17B10ALDH1A1CYP3A4 | |
| SCHEMBL463542 | 0.74 | AHR (0.72) | TTRTSHRHSD17B10ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260063601-A1 | PLASMA METABOLOME AS A PREDICTOR OF BIOLOGICAL AGING | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY (US) | 2026-03-05 | — | — | US | disclosed |
| US-12080432-B1 | Plasma metabolome as a predictor of biological aging | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2024-09-03 | — | — | US | disclosed |
| CN-114660033-A | Method for rapidly detecting thyroxine T4 based on fluorescence resonance transfer | 武汉海关技术中心 | 2022-06-24 | — | — | CN | disclosed |
| EP-1790216-B1 | METHOD OF DETECTING ESTROGEN-LIKE SUBSTANCE BY USING PLANT | UNIV HOKKAIDO NAT UNIV CORP (JP) | 2010-04-21 | — | — | EP | disclosed |
| US-20080199858-A1 | Method for Detecting Estrogen-Like Chemicals by Plant | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2008-08-21 | — | — | US | disclosed |
| EP-1790216-A1 | METHOD OF DETECTING ESTROGEN-LIKE SUBSTANCE BY USING PLANT | National University Corporation Hokkaido University (JP) | 2007-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260063601-A1 | PLASMA METABOLOME AS A PREDICTOR OF BIOLOGICAL AGING | PLPBP, PLCG1, PLA2G1B | TTR 437/4885TSHR 2218/4885HSD17B10 823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.